Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Adjusted enterprise value = Exelon

<< Previous

Bullboard Posts

Next >>

Comment by EbbFlow88on Sep 08, 2023 11:33am

122 Views

Post# 35626217

RE:RE:RE:Adjusted enterprise value = Exelon

wofats wrote: Is this a good price yet? 4.28 was the year low.
I suppose if you were averaging down it is .
The quarter is almost done . Perhaps a new position is being started by retail
Maybe stock buy back? They have bought almost 800,000 shares since last quarter .

4:22:30 4.40 -0.02 8,700 19 Desjardins 80 National Bank

14:22:30 4.40 -0.02 1,300 19 Desjardins 79 CIBC

Nice catch on this btw. Someone from Desjardins and CIBC outside of Knights buybacks have been loading up. Hard to tell if CIBC is the same person but Desjardins likely is.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 14, 2024